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95% confidence interval, 1.67 to 72.4). Conclusions: CRP levels, which were measured 
at stable phase, are not associated with infarct size but are significantly associated with 
long-term mortality of acute myocardial infarction in the reperfusion era. 
1002-101 Increased Levels of Macrophage Colony Stimulating 
Factor Measured Beyond the Acute Phase Can Predict 
Future Cardiac Events in Patients With Unstable Angina 
Loukianos S. Rallidis , Maria G. Zolindaki. Kyriakos P. Poulopoulos, Panagiotis C. 
Pentzeridis, Aggeliki Ii. Velissaridou, Evangelos G. Papasteriadis, General Hospital of 
Nikea. Piraeus, Greece 
Background Inflammation plays a central role in the pathogenesis of coronary events. 
We evaluated the long-term prognostIc value of macrophage colony stimulating factor 
(MCSF), interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) in patients (pts) with 
unstable angina (UA). 
Methods We studied 119 consecutive pts, aged 58+10 years, with Braunwald Class lllb 
UA. On admission, at discharge and 6 weeks later MCSF, IL-6 and TNF-a were mea- 
sured and the pts were followed up for 2 years. Clinical end points were: cardiac death, 
readmission for acute coronary syndromes and revascularization. 
Results 113 pts completed the follow-up while 2 died of non-cardiac causes. Of the 
remaining Ill pts. 39 (35.1%) had a cardiac event (2 deaths, 15 revascularizations and 
22 readmissions for acute coronary syndromes). Only MCSF and IL-6 levels at 6 weeks 
were higher in pts with cardiac events compared to those without events (424 versus 306 
pqiml, p=O.O006 and 6.6 versus 4.5 pglml, p=O.Ol, respectively]. Logistic regression 
analysis showed that MCSF levels at 6 weeks were the only independent predictors of 
future events with an adjusted odds ratio for events of 4.1 (95% confidence interval 1 .I to 
14.6, p=O.O3). The P-year survival free from cardiac events was significantly lower in pts 
with MCSF levels in the highest tertile (values 2468 pg/ml) compared to pts with values 
~468 pg/ml (Figure). 
Conclusion We suggest that increased MCSF levels beyond the acute phase are 
strongly predictive of long-term outcome in pts with severe UA. 
1002-l 02 Treatment of Obstructive Sleep Apnea Syndrome May 
Decrease the Risk of lschemic Events 
Olivier Milleron, RBmi Pilli&?, Arlene Foucher, Michel Leroy, Nicolas Mansencal, 
Guillaume Jondeau. Bernadette Raffestm, Olivier Dubourg. HBpital Ambroise Par& 
Boulogne, France 
Background: Obstructive sleep apnea syndrome (OSAS) is associated with an increased 
cardiovascular morbidity. The aim of our study was to evaluate the role of OSAS treat- 
ment on cardiovascular events. 
Methods: We prospectively studied 54 CAD-patients (mean age 57.3 f 10.1 years) with 
OSAS defined as apnea-hypopnea index (AHI) > 15ihour. All pts had proven CAD at cor- 
onary angiography. Twenty five pts were treated (group I) with continuous positive airway 
pressure (n=20) or OSAS surgery (n=5); 29 pts had no OSAS treatment (group II). The 
primary endpoint was the composite incidence of cardiovascular deaths, ischemic events 
and cardiovascular hospitalizations. 
Results: Mean follow-up was 74.7 * 31 months. The 2 groups were not significantly dif- 
ferent according to age, sex, BMI, smoking history. hypertension, hypercholesterolemia, 
diabetes mellitus, CAD and anti-ischemic therapy. The primary endpoint was observed in 
6 pts (24%) of group I and in 17 pts (58%) of group II (p<O.Ol). The risk of deaths, 
ischemic events and cardiovascular hospitalizations was significantly decreased by 
OSAS treatment (OR 0.3, 95%CI 0.11 - 0.76; p<O.Ol). 
Conclusion: Our data suggest that effective treatment of obstructive sleep apnea syn- 
drome in CAD-patients is associated with a significant decrease in cardiovascular 
events. 
1002-l 03 Acute Coronary Syndrome Patients With ST-Segment 
Depression Have Substantial Mortality Rates but 
Undergo Less Aggressive Management Strategies: 
Insights From the Global Registry of Acute Coronary 
Events (GRACE) 
Shaun G. Goodman Christopher B. Granger, Kami White, David Brieger. And@ Budaj, 
Omar H. Dabbous, Philippe Gabriel Steg, on behalf of the GRACE Investigators, St. 
Michael’s Hospital, Toronto, ON, Canada, HBpital Bichat, Paris, France 
Background: In patients presenting with suspected acute coronary syndromes (ACS), 
the electrocardiogram (ECG) remains the most immediately accessible and wdely 
employed diagnostic tool for guiding subsequent investigation and therapy. Current 
guidelines recommend a more aggressive management strategy in ST elevation (Sfl) or 
depression (Sd); however, a contemporary evaluation of the prognostic value of the 
ECG in a large, unselected population of ACS patients is lacking. 
Methods: We examined characteristics of, and the prognoses associated with, the initial 
ECG in 19,453 ACS patients enrolled in GRACE (April 1999.December 2001). GRACE is 
a prospective, multinational, observational study of patients hospitalized with ACS in 94 
centers in 15 countries from 4 continents, including Europe and the Americas. 
Results: Initial ECGs were grouped according to type of ST-segment deviation or T- 
wave inversion to.1 mV in Z2 leads) or left bundle branch block (LBBB): 
ECG Subgroup STlLBBB Sd T wavd 
N (%) 7325 (37.7) 3296 (17.0) 2762 (14.3) 
Median (25’,75’” age, years 65.4 (54.5. 70.0 (60.1, 64.9 (55.5, 
percentiles) 74.9) 77.6) 74.1) 
Men (%) 69.5 59.2 62.5 
Prior diabetes (%) 22.3 27.8 23.3 
Killip class II-IV (%) 22.1 23 14.8 
Cardiac marker + (%) 83.3 69.8 49.0 
Hospital angiography (%) 53.3 47.1 50.9 
Hospital revascularization (%) 41.2 30 31.6 
Hospital death (%) 7.0 5.6 2.1 
Death post-discharge to 6- 6 8.4 4.4 
month5 (46) 
Others 











Conclusions: Despite having high risk characteristics and sub&&al mortality rates, 
patients presenting with STL ACS undergo hospital angiography or revascularization at 
rates similar to other no&l? ACS patients. This finding suggests that guideline-recom- 
mended risk stratification based upon the initial ECG is not consistently followed. 
1002-l 04 Difference Between Positive Remodeling and Negative 
Remodeling at the Coronary Culprit Lesion in Acute 
Coronary Syndromes 
Shoichi Ehara Yoshiki Kobayashi, Kenei Shimada. Minoru Yosiyama. Kazuhide 
Takeuchi, Junichi Yoshikawa, Makiko Ueda, Osaka City University. Osaka, Japan 
Backgrounct According to recent IVUS studies, positive remodelmg (PR) at the culprit 
lesion has been observed in almost 50% of patients with acute coronary syndrome (ACS) 
and negative remodeling (NR) in 30%. However, little is known about the difference 
between PR and NA in ACS. Recent hlstopathological studies have revealed that PR 
occurred in plaque rupture with lipid core. whereas plaque erosion resulted in NR. The 
purpose of this study is to investigate the difference between PR and NR at the culprit 
leston in ACS. Methods and Results: Preinterventional IVUS images of 111 patients 
with ACS (56 acute myocardial infarction, 55 unstable angina) were identified. The 
remodeling ratio (RR) was deftned as the ratio of the external elastic membrane (EEM) 
areas at the culprit lesion to the EEM areas at the proximal reference site. Positive 
remodeling (PR) was defined as an RR>l.05; Negative remodeling (NR), as an 
AR<0.95. PR was observed in 44 of the Ill patients (40%), while NR was observed in 
41 patients (37%). Patients with PR were significantly older than with NR (66+9 vs 
58210, p< 0.0001). Calcifications in the lesion were more frequent in patients showing 
PR than in oatients showina NR (PR: 91% YS NR: 46% !x 0.0001). On the other hand, ln 
patients wiih NR, no calcif&tion’plaque was the most frequent. Concluslolr These find- 
mgs strongly suggest that PR relates to old age and calcification in patients with ACS. 
The differences in patient characteristics and plaque morphology behwen PR and NR in 
ACS may reflect different progression mechanisms of the two arterial remodelings. 
1002-l 05 Predictors of One-Year Death in Men and Women: 
GUSTO-IV Acute Coronary Syndrome 
Cvnthia M. Westerhout Jan-Paul Otterwnger, Paul W. Armstrong, Judith S. Hochman, 
Stefan James, Lars Wallentin. Elliot S. Barnathan, E. Magnus Ohman, Maarten L. 
Simoons, Eric Boersma, Erasmus Medical Centre, Rotterdam. The Netherlands 
??ackgroundRrewous studies have noted gender differences in baseline characteristics 
of non-ST-elevation acute coronary syndrome (NSTE-ACS) patients but their impact on 
long-term prognosis IS unclear in such a contempory and large sample. Methods: In 
GUSTO IV ACS, 7800 patients wth NSTE-ACS were randomised to 24-h, 48-h infusion 
abciximab or placebo. Cox regrewon was used to identify predictors of l-year death. 
Results: Women made up 38% of the population and were older, more often had diabe- 
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tes or hypertension and racewed fewer revascularization procedures (22%) within 30 
days than man (35%, p<O.OOl). Unadjusted l-year swvival was not significantly different 
between men (8%) and women (9%). Advanced age (HRl.06 95%Cl(1.05-1.07)), histo- 
ries of myocardial infarction (MI) (1.7 (1.4-2.0)) 01 heart failure (1.7(1.3-2.1)), diabetes 
(1.3(1 .l-1.6)). hypercholesterolemia (1.3(1 .O-1.5)), ascending quartiles of troponin 
(1.4(1.0-1.9). 1.7(1.3-2.4), 2.2(1.6-3.0)), MI within 30 days (3.4(2.7-4.3)), elevated heart 
rate (1 .OZ(l .Ol-1.02)) and serum creatinine levels (1.4(1.3-1.6)) were associated with a 
higher l-year mortality in both genders, whereas, angioplasty within 30 days was associ- 
ated with lower risk of death (0.5(0.4-0.7)). ST-depresslon (1.3(1.0-l .7) p(interac- 
tion)<0.05) on admission and CRP>lOmg!L (1.3(1.0-l -8) p(interactlon)c0.05) were 
predictors of l-year death in men but not women. Men with Ml on admission were at 
pr* 8hrs 16hrs 24hrs 
Procedure successful (N) 54 
Tropon~n I - rise above 0.1 mgidL (N,(%)) l(2) 6(12) 5(10) 8(16) 
CWCK-MB rise (U/L) 0 0 0 0 
In-hospital events (N) 0 
ECG changes 2 
post procedure (N) 
Adverse events at 15 days (N) 2 
March 19,2003 
lower risk of death (0.6(0.4-0.8) p(interaction)=O.OOZ) than women or patients without Ml 
on admission. Conclusions: Although long-term prognosis is comparable between men Conclusion: Surprisingly, significant Troponin I wes were found in up to 16% of patients 
and women with NSTE-ACS. some predictors of death differ, which may have important 
that underwent a diagnostic angiogram for stable coronary artery disease, with no sigmf- 
icant lesions present. These findings may have an impact on conclusions drawn from 
implications for risk management and choice of treatment. previous lntetventional cardiology trials that suggested future events depended upon 
Troponin status following intervention. 
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1003-89 Is Enhanced External Counterpulsation Effective for 
Angina Relief in Diabetic Patients Who Are Not 
Candidates for Transcatheter Intervention? 
Georaiann C. Linnemeier, Elizabeth D. Kennard, Ozlem Soran, Shetyl F. Kelsey, 
University of Pittsburgh, Pittsburgh, PA 
Background: Percutaneous coronary Intervention in the diabetic patient is problematic. 
Enhanced external counterpulsation (EECP) is a noninvasive analogue of the intra-aortic 
balloon pump designed to increase myocardial perfusion pressure and decrease cardiac 
workload. EECP has been demonstrated to be safe and effectwe in treating angina; how- 
ever, the effectiveness of EECP for the treatment of angina in diabetic patients who are 
not considered candidates for transcatheter lntewention is unknown. 
Methods: We analyzed demographic and clinical outcome data from 616 diabetic 
patients (from 32 sites) diagnosed with Canadian Cardiovascular Society (CCS) class Ill 
or IV angina who were not revascularization candidates by referring physician’s assess- 
ment. EECP was given l-2 hours daily with 79% of patients completing a course of treat- 
ment (mean, 37 hours). Patients were followed for six months. 
Results: The mean age was 66 years. and 36% were female. Coronary artery disease 
was of long duration (mean, 11 years), frequently multwessel (81%), and most patients 
had prior percutaneous coronary intervention (74%) or coronary artery bypass surgery 
(72%). Congestive heart failure (44%), and previous myocardial infarction (73%) were 
reported often (mean left ventricular ejection fraction, 45%). Patients were highly symp- 
tomatic, reporting 11.5 episodes of angina/week, requirmg 10.2 sublingual nitroglycerin1 
week. Medical management was considered optimal. Upon completion of treatment, 
88% of patients reported a decrease of >= 1 CCS angina class wth 63% reporting class 
II, I, or no angina. There was a decrease of 8.7 angina1 episodes/week with a concomi- 
tant decrease of 13.2 nitroglycerin/week. At xx-month follow-up, angina reduction was 
maintained in 74% of patients with 74% repomng class II, I, of no angina. 
Conclusion: Despite steady improvement in transcatheter interventional techniques and 
outcomes, there is a growing population of patients who have exhausted the revascular- 
ization armamentarium. Novel treatments such as EECP can offer angina reduction with 
maintenance of benefit for select diabetic patients with advanced coronary artery dis- 
ease. 
Huerin Melina, B. Rolong, R. Henquin, R. Zilberberg, C. Gambarte, 0. Mendoza, M. 
Kriskovich, N. Vainstein, C. Zeballos, L. Guzman, lnstituto Cardiovascular de Buenos 
Aires, Buenos Aires, Argentina 
Increasing levels of homocysteine are strongly associated with the incidence of cardio- 
vascular disease. Recent report appears to indicate a clinical benefit in reducing 
homocysteine levels. Even though it is well established the effectiveness I” reducing 
homocysteine levels with wtamine B complex, the effect of diet is not well documented. 
The aim of the present study was to determine the role of folate-rich diet I” reducing 
homocysteine levels and to compare it effect with the vitamin reduction and with the reg- 
ular secondary prevention recommendations. Sixty patients with prior hlstory of CAD 
were randomly assigned to three different treatments strategies for a three months 
period. The vitamin group (Group V). received vitamin 69: 2.5 mg, B6: 25 mg, and 812: 
0.5 mg; the diet group recewed folate-rich diet (Group D) and a third group received the 
usual secondary preventIon recommendations, and sewed as control (Group C). Base- 
line and 3 months homocysteine levels were measured in all pts. Results: The compli- 
ance with the treatment strategy was 99% for group V and 80% for group D, (p: 0.001). 
Conclusions This prospective randomized study shows that f&ate-rich diet did not 
show any significant benefit in decreasmg homocysteine levels despite a relatively high 
compliance with the diet as compare with the usual secondary prevention recommenda- 
tlons. As expected, vitamin treatment successfully decrease homocysteine levels and 
was well tolerated. 

























1003-114 Mildly Reduced Creatinine Clearance Is Associated With 
Coronary Artery Disease in Women: The NHLBI- 
Sponsored WISE Study 
Marian 8. Olson, Richard Holubkov, Linda Fried, Virgina Reeser, Sunil Mankad, Carl J. 
Pepine, Richard Kerensky, C. Noel Bairey Merz. Barry L. Sharaf, George Sopko, William 
J. Rogers, Steven E. Reis, University of Pittsburgh, Pittsburgh, PA 
1003-90 Cardiac Troponin I Rise Equally Occurs After 
Diagnostic Coronary Angiograms in Stable Patients 
Glenn Van Lanqenhove, Paul Vermeersch, Middelheim Hospital, Antwerp, Belgium 
Background: Troponin I has been suggested as an excellent and early marker of unsta- 
ble coronary artery disease. It has been lknked to future outcome of patients admitted to 
the hospital with unstable coronary syndromes, and in patients that received Interven- 
tional treatment. No literature exists on the occurrence of Troponin I rise following a diag- 
nostic angiogram 
Methods: Patients were only included if they did not have flow-llmiting lesions in their 
coronary artery tree. We prospectively measured Troponin I values before, and 8, 16 and 
24 hours after a diagnostic angiogram and at 14 days after the index procedure. Other 
cardiac enzymes were also assessed. 
Results: No events occurred during hospital stay nor the 14 day follow-up period. A sum- 
mary of the data available IS shown in the table. 
Background: Mild renal insufficiency is associated with an increased risk for cardiovascu- 
lar events in women with coronary artery disease (CAD). However, the relationship 
between mild renal insufficiency and atherosclerotic CAD has not been Investigated. 
Methods: 721 women with chest pal” underwent quantitative coronary angiography, risk 
factor and serum creatinine assessment in the Women’s lschemia Svndrome Evaluation 
(WISE) Study. Estimated creatinine clearance (mllmin) was calculated from serum creat- 
inine usino the Cockroft-Gault eouatlon. Of these. 248 i34%) had an estimated creatinme 
clearance of 50-80 mllmin, defined as mild renal insufficiency; 473 had an estimated 
clearance greater than 80 mllmin. normal renal function. Women with one or more >50% 
dtameter stenosis were classified as having significant CAD. CAD severity score was cal- 
culated using a modified Gensinl index. Interleukin-6 levels were measured in 508 
women. 
Results: As compared to women with normal creatmine clearance, those with mild renal 
Insufficiency were older (64 vs. 54 yrs., p<O.OOl) were more likely have higher systolic 
blood pressure (p=O.Ol), dyslipidemia (p=O.O5) and significant CAD (49% vs 30%, p 
=O.OOl). Modified Gensmi index scores were higher in these women (16 +/-I6 vs. 12 +I- 
12, p< 0.001). Women with mild renal insuffkxncy were 2.3 times more likely to have 
significant CAD (95% Cl 1.6.3.O)(p< 0.001) Mild renal insufficiency was associated with a 
1.6.fold (95% Cl=1 .O-2.6) wreased risk of CAD after adjustment for age. risk factors, 
interleukin 6 levels and use of hormone replacement therapy (pc 0.05). Similar finding 
were noted when using serum creatinine to define renal function. Serum creatinine levels 
of 1.2-1.9, defined as mild renal insufficiency, were associated with a 3.2 fold (95% 
CLl.4.7.2) increase of significant CAD independent of risk factors (pc 0.01) 
